Roble, Belko & Company, Inc Organon & Co. Transaction History
Roble, Belko & Company, Inc
- $634 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding OGN
# of Institutions
794Shares Held
193MCall Options Held
1.71MPut Options Held
865K-
Black Rock Inc. New York, NY32.6MShares$481 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$446 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.76MShares$144 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$133 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL7.49MShares$111 Million0.31% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $3.76B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...